The "morphine rule" is not a hard and fast rule, more like a rule of thumb. And tianeptine itself binds to mu opioid, doesn't need dealkylation. Strange drug.
I was just being my pedantic self.
No offence intended. It always bothers me when something throws all my education out of the window.
There are certainly 6and I believe 7 moieties that bind to the mu receptor. In one book, etorphine's moieties are listed as are the analogues where the N-pentyl is replaced by a 2-phenylethyl and it's something like:
-Aromatic A (a-ring)
-Phenol or bioisostere on a-ring.
-Quaternary Carbon
-Nitrogen lone-pair
-Interaction of oxygen lone-pairs of 6 -OCH3 & 18-OH (etorphine with 6 -OH3 removed is only x25 M)
-Aromatic B (c-ring)
But I say that an alkene is also an important binding site. Overlay allyl prodine & 14-cinnamyloxy codeinone.
The rigidity of the compound is also important.
Duel agents (agonists) are much more potent and much more euphoric
mu/delta
mu/NOP (ORL1)
mu/NMDA
mu/dopamine release
As you know, a simple mu/NMDA/dopamine releaser like
trans nortilidine turned up in Germany just once (reported by 7 users on the
Land der Träume website (German). All were experienced in tilidine users and they all placed trans-nortilidine it at the very top of their favourite drug lists. It has the molar potency of morphine but the synthetic pathway was so long (5 steps), complex & low-yielding & the precursors so expensive that it was not economical. I think they paid €60-€80 per gram and that was directly from a German RC maker.
Of course, all of the papers & patents are on the Eunoia Disc but that is all from the 60s & 70s. Since then I discovered a new (to me) reagent that was discovered in 2007 that can produce the trans material (so no separation/epimerization steps) and if I am right, it's just 2 steps using very common reagents.
Sad really because as things stand, lots of fentanyl analogues and a handful of other potent opioids are flooding the market. Dangerous stuff with a supply chain that doesn't care about the end users.